Teva Crushes Earnings as Pfizer Struggles to Replace COVID Revenue

Core Insights - Pfizer and Teva Pharmaceutical Industries reported third-quarter earnings, indicating contrasting performance trends between the two companies [1] Company Performance - Pfizer is showing positive growth in its earnings, while Teva is experiencing challenges [1] - The earnings reports highlight the divergent paths of these two major pharmaceutical companies [1]